ASTRAZENECA PLC 4

SVP and Group Controller Mani Sharma acquired 19,267.4659 AstraZeneca PLC ordinary shares via the company’s Share Incentive Plan, a compensation-related share award valued at roughly $3.15 million.

On August 6, 2026, AstraZeneca PLC SVP and Group Controller Mani Sharma acquired 19,267.4659 ordinary shares under the issuer’s Share Incentive Plan at an effective price of approximately $163.34 per share (equivalent to GBP121.26, translated at GBP1.00 = $1.3470), for an estimated transaction value of about $3.15 million. This acquisition is a compensation-related award rather than an open-market purchase and increased Sharma’s direct ownership of AstraZeneca ordinary shares; based on the provided current market price of $160.38 per share, the post-transaction holdings are worth roughly $3.09 million. The filing reflects a routine share plan acquisition, albeit of meaningful size, and does not indicate any sale or disposition of shares by the insider.

Filing Facts

CIK

901832

Ticker

AZN

Form

4

Source Type

fda

Accession

0002122411-26-000001

Alert Tier

7